The clinical and immunological features of the post-extracorporeal shock wave lithotripsy anti-glomerular basement membrane disease

References

• McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162–1172.
   PubMed Web of Science ®Google Scholar
• Cashman SJ, Pusey CD, Evans DJ. Extraglomerular distribution of immunoreactive Goodpasture antigen. J Pathol. 1988;155(1):61–70.
   PubMed Web of Science ®Google Scholar
• Saus J, Wieslander J, Langeveld JPM, et al. Identification of the Goodpasture antigen as the α3(IV) chain of collagen IV. J Biol Chem. 1988;263(26):13374–13380.
   PubMed Web of Science ®Google Scholar
• Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 1994;46(3):823–829.
   PubMed Web of Science ®Google Scholar
• Yang R, Hellmark T, Zhao J, et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. JASN. 2007;18(4):1338–1343.
   Web of Science ®Google Scholar
• Netzer KO, Leinonen A, Boutaud A, et al. The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem. 1999;274(16):11267–11274.
   PubMed Web of Science ®Google Scholar
• Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348(25):2543–2556.
   PubMed Web of Science ®Google Scholar
• Donaghy M, Rees A. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. 1983;322(8364):1390–1393.
   Google Scholar
• Stevenson A, Yaqoob M, Mason H, et al. Biochemical markers of basement membrane disturbances and occupational exposure to hydrocarbons and mixed solvents. QJM. 1995;88(1):23–28.
   PubMedGoogle Scholar
• Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014;86(5):905–914.
   PubMed Web of Science ®Google Scholar
• Olson SW, Arbogast CB, Baker TP, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. JASN. 2011;22(10):1946–1952.
   Web of Science ®Google Scholar
• Basford AW, Lewis J, Dwyer JP, et al. Membranous nephropathy with crescents. J Am Soc Nephrol. 2011;22(10):1804–1808.
   PubMed Web of Science ®Google Scholar
• Jia XY, Hu SY, Chen JL, et al. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int. 2014;85(4):945–952.
   PubMed Web of Science ®Google Scholar
• Pedchenko V, Bondar O, Fogo AB, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343–354.
   PubMed Web of Science ®Google Scholar
• Bazari H, Mauiyyedi S. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-2002. A 75-year-old man with acute renal failure five months after cystoprostatectomy and urethrectomy for carcinoma. N Engl J Med. 2002;346(5):353–360.
   PubMedGoogle Scholar
• Blas A, 3rd, McGill R, Sandroni S. Case 4-2002: cancer-associated obstruction and glomerular damage. N Engl J Med. 2002;346(22):1751–1752.
   PubMed Web of Science ®Google Scholar
• Weber M, Pullig O, Boesken WH. Anti-glomerular basement membrane disease after renal obstruction. The Lancet. 1990;336(8713):512–513.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Takeuchi E, Kamata K. A possible clue for the production of anti-glomerular basement membrane antibody associated with ureteral obstruction and hydronephrosis. Case Rep Nephrol Dial. 2015;5(1):87–95.
   PubMed Web of Science ®Google Scholar
• O'Hagan E, Mallett T, Convery M, et al. Anti-GBM disease after nephrectomy for xanthogranulomatous pyelonephritis in a patient expressing HLA DR15 major histocompatibility antigens: a case report. Clin Nephrol Case Stud. 2015;3:25–30.
   PubMedGoogle Scholar
• Türk C, Petřík A, Sarica K, et al. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016;69(3):475–482.
   PubMed Web of Science ®Google Scholar
• Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol. 2006;50(5):981–990; discussion 90.
   PubMed Web of Science ®Google Scholar
• Karlsen SJ, Smevik B, Hovig T. Acute morphological changes in canine kidneys after exposure to extracorporeal shock waves. A light and electron microscopic study. Urol Res. 1991;19(2):105–115.
   PubMedGoogle Scholar
• Recker F, Hofmann W, Bex A, et al. Quantitative determination of urinary marker proteins: a model to detect intrarenal bioeffects after extracorporeal lithotripsy. Journal of Urology. 1992;148(3 Part 2):1000–1006.
   PubMed Web of Science ®Google Scholar
• Delvecchio F, Auge BK, Munver R, et al. Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction. J Urol. 2003;169(4):1526–1529.
   PubMed Web of Science ®Google Scholar
• Guerin V, Rabian C, Droz D, et al. Anti-glomerular-basement-membrane disease after lithotripsy. Lancet. 1990;335(8693):856–857.
   PubMed Web of Science ®Google Scholar
• Iwamoto I, Yonekawa S, Takeda T, et al. Anti-glomerular basement membrane nephritis after extracorporeal shock wave lithotripsy. Am J Nephrol. 1998;18(6):534–537.
   PubMed Web of Science ®Google Scholar
• Xenocostas A, Jothy S, Collins B, et al. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis. 1999;33(1):128–132.
   PubMed Web of Science ®Google Scholar
• Sellin L, Quack I, Weiner SM, et al. Nephrolithiasis and hematuria-sometimes a stony road to diagnosis. Clin Nephrol. 2005;64(2):151–154.
   PubMed Web of Science ®Google Scholar
• Cranfield A, Mathavakkannan S. Goodpasture's disease following extracorporeal shock wave lithotripsy: a case report & literature review. Clin Case Rep. 2015;3(3):160–164.
   PubMed Web of Science ®Google Scholar
• Fisher M, Pusey CD, Vaughan RW, et al. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int. 1997;51(1):222–229.
   PubMed Web of Science ®Google Scholar
• Koga H, Matsuoka K, Noda S, et al. Cumulative renal damage in dogs by repeated treatment with extracorporeal shock waves. Int J Urol. 1996;3(2):134–140.
   PubMedGoogle Scholar
• Kang DH, Cho KS, Ham WS, et al. Comparison of high, intermediate, and low frequency shock wave lithotripsy for urinary tract stone disease: systematic review and network meta-analysis. PLoS One. 2016;11(7):e0158661
   PubMed Web of Science ®Google Scholar
• Chung JM, Park BK, Kim JH, et al. Impact of repeated extracorporeal shock wave lithotripsy on prepubertal rat kidney. Urolithiasis. 2018;46(6):549–558.
   PubMed Web of Science ®Google Scholar
• Gu QH, Xie LJ, Jia XY, et al. Fever and prodromal infections in anti-glomerular basement membrane disease. Nephrology (Carlton.). 2018;23(5):476–482.
   PubMed Web of Science ®Google Scholar
• Lubec G. Anti-glomerular basement membrane disease after lithotripsy. Lancet. 1990;335(8702):1405.
   PubMed Web of Science ®Google Scholar
• Gilbert BR, Riehle RA, Vaughan ED. Extracorporeal shock wave lithotripsy and its effect on renal function. J Urol. 1988;139(3):482–485.
   PubMed Web of Science ®Google Scholar
• Banner B, Ziesmer D, Collins LA. Proliferative glomerulopathy following extracorporeal shock wave lithotripsy in the pig. Journal of Urology. 1991;146(5):1425–1428.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yan Y, Cui Z, et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol. 2009;70(6):425–429.
   PubMed Web of Science ®Google Scholar
• Magnusson CG, Cesbron JY, Djurup R, et al. Raised serum IgG4 levels in patients with atopy and filariasis: application of an automated particle-counting immunoassay using monoclonal antibody. Int Arch Allergy Appl Immunol. 1986;81(3):238–244.
   PubMedGoogle Scholar
• Ljungstrom I, Hammarstrom L, Kociecka W, et al. The sequential appearance of IgG subclasses and IgE during the course of Trichinella spiralis infection. Clin Exp Immunol. 1988;74(2):230–235.
   PubMed Web of Science ®Google Scholar
• Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006;69(5):894–899.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Besser M, Schwarting R, et al. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest. 1986;78(1):241–248.
   PubMed Web of Science ®Google Scholar
• Lerner RA, Dixon FJ. The induction of acute glomerulonephritis in rabbits with soluble antigens isolated from normal homologous and autologous urine. J Immunol. 1968;100(6):1277–1287.
   PubMed Web of Science ®Google Scholar